GlassScriptPhysician profile
Dhaval M Patel
NPI 1497899009
$7,976.16
in general payments reported to CMS, 2019-2025
12 companies · $606 in 2025
The $606 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,224 · 2020: $120 · 2021: $518 · 2022: $2,227 · 2023: $2,817 · 2024: $463 · 2025: $606.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,702 · Travel and Lodging: $1,184.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,702.04 |
| Travel and Lodging | $1,184.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $2,720.41 | 2019-2025 | Xeomin |
| Musculoskeletal Transplant Foundation INC. | $2,210.69 | 2022-2023 | |
| Mentor Worldwide LLC | $1,352.84 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Allergan, INC. | $911.67 | 2019-2022 | |
| Galderma Laboratories, L.P. | $554.45 | 2019-2025 | Dysport |
| Medtronic, INC. | $104.26 | 2021-2024 | Harmony |
| Sientra, INC. | $32.49 | 2021 | |
| Boston Scientific Corporation | $24.79 | 2020 | |
| Abbvie INC. | $17.52 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.25 | 2025 | Entyvio |
| Teleflex LLC | $15.68 | 2025 | Manta |
| Pacira Pharmaceuticals Incorporated | $14.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dhaval Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.